Hidehisa Asada, PhD, MBA, is one of the founders of Ezose Sciences Inc. and has served as a company officer and vice president of research and development since its incorporation in March 2009. Prior to joining Ezose Sciences Inc., Dr. Asada worked on research and licensing projects at Shionogi & Co., Ltd. for both the Therapeutics and Diagnostics Divisions. As a project leader of Diagnostics, he led the team in the global development of the brain natriuretic peptide test at Oslo University, Glasgow University, Mayo Clinic and Framingham Heart Study. In 2007, he initiated the establishment of a technology-based spin-off company with Hokkaido University and launched Ezose Sciences Inc. with funding from Shionogi & Co., Ltd. and Sumitomo Bakelite Co., Ltd. Dr. Asada received a PhD in immune biology from Gifu Pharmaceutical University and an MBA from Kansei Gakuin University in Japan.